Curative Health Services Appoints Gary Blackford Chief Executive Officer.Business Editors HAUPPAUGE, N.Y.--(BUSINESS WIRE)--Sept. 20, 2001 Curative Health Services health services Managed care The benefits covered under a health contract , Inc. (Nasdaq: Cure) today announced that Gary Blackford has been named Chief Executive Officer of the Company, effective immediately. Blackford joined the Curative Board of Directors in July and brings extensive health care, operations, and finance experience with a focus on the specialty pharmacy industry to his new position. John Prior, who has served as interim CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. since March, remains president of Curative. Anthony Leiker remains president of eBioCare, a wholly owned subsidiary Wholly Owned Subsidiary A subsidiary whose parent company owns 100% of its common stock. Notes: In other words, the parent company owns the company outright and there are no minority owners. acquired by the Company in March. "Gary brings recognized leadership and expertise to this top management spot. His experience in guiding dozens of major health care transactions and integrations at ValueRx and MedIntell will be a great asset to Curative," said Joseph Feshbach, Executive Chairman. "We particularly look forward to his insight in the specialty pharmaceutical arena as we work toward building and strengthening Curative Health Services. Together with John Prior and Tony Leiker, we believe the Company now possesses the top management team necessary to achieve the ambitious goals we have for the Company." Blackford, 44, was instrumental in the turnaround of ValueRx, a multi-billion dollar pharmacy benefit management A Pharmacy Benefit Manager (PBM) is a third party administrator of prescription drug programs. They are primarily responsible for processing and paying prescription drug claims. (PBM PBM - play by mail. See play by electronic mail. ) company, which was sold to Express Scripts in 1998. He was responsible for the re-engineering of the company's organizational structure  This article has no lead section.To comply with Wikipedia's lead section guidelines, one should be written. , including a complete overhaul of systems/communications infrastructure, a consolidation of facilities, a reduction of litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute. When a person begins a civil lawsuit, the person enters into a process called litigation. and adversarial matters, and divestiture of non-core business units. "I am excited about this expanded role to help maximize the potential opportunities Curative has in its respective marketplaces," Blackford said. "Both John and Tony have extensive experience in their particular operations, and I look forward to working with both of them to further the growth of the Company." Previously, Blackford served MedIntell Systems Corporation as Chief Operating Officer Chief Operating Officer (COO) The officer of a firm responsible for day-to-day management, usually the president or an executive vice-president. and Chief Financial Officer. During his tenure, he executed the turnaround of this specialty pharmacy management company, which was sold to Value Health, Inc. in 1995. Blackford also has a strong background in corporate law and finance. He was a Partner with Popham, Haik, Schnobrich & Kaufman, Ltd. He received a B.B.A. from the University of Iowa Not to be confused with Iowa State University. The first faculty offered instruction at the University in March 1855 to students in the Old Mechanics Building, situated where Seashore Hall is now. In September 1855, the student body numbered 124, of which, 41 were women. , a J.D. from Creighton University and is a Certified Public Accountant Certified Public Accountant (CPA) An accountant who has met certain standards, including experience, age, and licensing, and passed exams in a particular state. . About Curative Health Services Curative Health Services is a leading disease management company in chronic wound care. Curative provides a broad continuum of services to health care providers through a nationwide network. This national network of over 112 hospital-based Wound Care Centers in 33 states, has offered comprehensive treatment to over 300,000 patients, achieving more than a 90% patient satisfaction rate. About eBioCare eBioCare, a subsidiary of Curative Health Services, provides services to patients and physicians that facilitate the health care management process. These include services such as direct-to-patient overnight distribution of biopharmaceuticals, medication management, and a comprehensive resource of chronic condition medical information. This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the actual results, performance or achievements of the Company, or industry results, to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. Factors that might cause such differences include, but are not limited to, the termination or non-renewal of a material number of contracts, an inability to obtain new contracts, changes in the government regulations relating to the Company's wound care operations or the operations of eBioCare, changes in the regulations governing third party reimbursements for Curative services, manufacturing shortages of products sold by eBioCare, and the other risks and uncertainties detailed in the Company's filings with the Securities and Exchange Commission. Readers of this press release are referred to the Company's Annual Report on Form 10-K Form 10-K A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information. Form 10-K See 10-K. for the year ended December 31, 2000 for further discussion of these and other factors that could affect future results. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion